TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Market Closed 01-23 16:00:00 EST

2.61

+0.06

+2.35%

盘后2.68

+0.07+2.68%

19:23 EST

High2.65	Low2.36	Vol87.73K
Open2.58	D1 Closing2.55	Amplitude11.27%
Mkt Cap30.21M	Tradable Cap24.95M	Total Shares11.57M
T/O220.65K	T/O Rate0.92%	Tradable Shares9.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":2.61,"timestamp":1769202000000,"preClose":2.55,"halted":0,"volume":87730,"hourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.61,"latestTime":"19:23 EST","volume":625,"amount":1633.4209,"timestamp":1769214232136,"change":0.07,"changeRate":0.02682,"amplitude":0.045977},"delay":0,"changeRate":0.023529411764705906,"floatShares":9560749,"shares":11574362,"eps":0.026128,"marketStatus":"Market Closed","change":0.06,"latestTime":"01-23 16:00:00 EST","open":2.58,"high":2.6473,"low":2.36,"amount":220647.56484200002,"amplitude":0.112667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.026128,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769418000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":2.55,"preHourTrading":{"tag":"盘前","latestPrice":2.55,"preClose":2.55,"latestTime":"08:15 EST","volume":71,"amount":181.47500599999998,"timestamp":1769174159512,"change":0,"changeRate":0,"amplitude":0.003333},"postHourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.61,"latestTime":"19:23 EST","volume":625,"amount":1633.4209,"timestamp":1769214232136,"change":0.07,"changeRate":0.02682,"amplitude":0.045977},"volumeRatio":0.5980476358429889,"impliedVol":0.9781,"impliedVolPercentile":0.2988},"requestUrl":"/m/hq/s/TXMD","defaultTab":"news","newsList":[{"id":"2605443383","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605443383?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:31","pubTimestamp":1769121060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 2.41% to $2.55 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.91% to 23,436.02 and the Dow Jones Industrial Average  rising 0.63% to 49,384.01.TherapeuticsMD Inc. closed 1.54% short of its 52-week high of $2.59, which the company reached on January 20th.The stock outperformed some of its competitors Thursday, as AbbVie Inc.  rose 0.91% to $218.11.Trading volume  remained 38,202 below its 50-day average volume of 135,841.Data source: Dow Jones Market Data, FactSet. Data compiled January 22, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2605141487","title":"TherapeuticsMD Inc. Stock Rises 12.1%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2605141487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605141487?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:33","pubTimestamp":1768944780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. climbed 12.1% to $2.50 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.4% to 22,954.32 and Dow Jones Industrial Average falling 1.8% to 48,488.59.TherapeuticsMD Inc. hit a new 52-week high, surpassing its previous peak of $2.37, which the company reached on January 16th.The stock outperformed some of its peers, as AbbVie Inc. fell 0.1% to $214.04.Trading volume totaled 274,848, compared to the 50-day average of 131,797.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2603640352","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2603640352","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603640352?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:31","pubTimestamp":1768429860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 1.90% to $2.14 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 1.00% to 23,471.75 and Dow Jones Industrial Average  falling 0.09% to 49,149.63.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 2.28% short of its 52-week high of $2.19, which the company achieved on January 9th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  rose 0.52% to $221.89.Trading volume  eclipsed its 50-day average volume of 125,714.Data source: Dow Jones Market Data, FactSet. Data compiled January 14, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2603529850","title":"TherapeuticsMD Inc. Stock Sheds 3.7%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2603529850","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603529850?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:35","pubTimestamp":1768253700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 3.7% to $2.08 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.3% to 23,733.90 and the Dow Jones Industrial Average rising 0.2% to 49,590.20.The stock's fall snapped a two-day winning streak.TherapeuticsMD Inc. closed 5.0% below its 52-week high of $2.19, which the company reached on January 9th.The stock underperformed when compared to some of its peers, as AbbVie Inc. remained unchanged.Trading volume totaled 364,802, compared to the 50-day average of 114,180.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2602011353","title":"TherapeuticsMD Inc. Stock Rallies 4.9%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2602011353","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602011353?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:34","pubTimestamp":1767994440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. rose 4.9% to $2.16 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 23,671.35 and the Dow Jones Industrial Average rising 0.5% to 49,504.07.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. hit a new 52-week high, surpassing its previous peak of $2.15, which the company achieved on January 6th.The stock outperformed some of its peers, as AbbVie Inc. fell 1.8% to $220.08.Trading volume totaled 127,014, compared to the 50-day average of 113,844.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2601463248","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2601463248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601463248?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:30","pubTimestamp":1767738600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  jumped 13.33% to $2.04 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.65% to 23,547.17 and the Dow Jones Industrial Average  rising 0.99% to 49,462.08.This was the stock's third consecutive day of gains.TherapeuticsMD Inc. closed 2.86% short of its 52-week high of $2.10, which the company achieved on November 17th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  rose 1.70% to $223.93.Trading volume  eclipsed its 50-day average volume of 105,461.Data source: Dow Jones Market Data, FactSet. Data compiled January 6, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2601837739","title":"TherapeuticsMD Inc. Stock Advances 9.1%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2601837739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601837739?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:32","pubTimestamp":1767648720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. rose 9.1% to $1.80 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 23,395.82 and the Dow Jones Industrial Average rising 1.2% to 48,977.18.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 14.3% short of its 52-week high of $2.10, which the company achieved on November 17th.The stock outperformed some of its peers, as AbbVie Inc. fell 4.0% to $220.18.Trading volume totaled 120,107, compared to the 50-day average of 105,210.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2600095919","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2600095919","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600095919?lang=en_us&edition=fundamental","pubTime":"2026-01-03 06:29","pubTimestamp":1767392940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 1.23% to $1.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.66% to 48,382.39 and the NASDAQ Composite Index  falling 0.03% to 23,235.63.The stock's rise snapped a three-day losing streak.TherapeuticsMD Inc. closed 32.38% short of its 52-week high of $2.44, which the company achieved on January 3rd.The stock outperformed some of its competitors Friday, as AbbVie Inc.  rose 0.36% to $229.31.Trading volume  remained 46,402 below its 50-day average volume of 106,455.Data source: Dow Jones Market Data, FactSet. Data compiled January 2, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2595748161","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2595748161","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595748161?lang=en_us&edition=fundamental","pubTime":"2025-12-31 06:32","pubTimestamp":1767133920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 2.38% to $1.64 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.24% to 23,419.08 and Dow Jones Industrial Average  falling 0.20% to 48,367.06.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 32.79% below its 52-week high of $2.44, which the company achieved on January 3rd.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  fell 0.48% to $229.74.Trading volume  remained 56,070 below its 50-day average volume of 114,712.Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2595588753","title":"TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2595588753","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595588753?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:34","pubTimestamp":1767044040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 3.4% to $1.68 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.5% to 23,474.35 and Dow Jones Industrial Average falling 0.5% to 48,461.93.The stock's fall snapped a two-day winning streak.TherapeuticsMD Inc. closed 31.1% short of its 52-week high of $2.44, which the company reached on January 3rd.The stock underperformed when compared to some of its peers, as AbbVie Inc. rose 0.4% to $230.84.Trading volume totaled 71,727, compared to the 50-day average of 288,008.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2595012758","title":"TherapeuticsMD Director Tommy G. Thompson Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595012758","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595012758?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:24","pubTimestamp":1767043453,"startTime":"0","endTime":"0","summary":"Tommy G. Thompson, a Director of TherapeuticsMD Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TherapeuticsMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL8PsvQg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TherapeuticsMD Director Tommy G. Thompson Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD","BK4007"],"gpt_icon":0},{"id":"2594215458","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2594215458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594215458?lang=en_us&edition=fundamental","pubTime":"2025-12-27 06:31","pubTimestamp":1766788260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 2.35% to $1.74 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.09% to 23,593.10 and Dow Jones Industrial Average  falling 0.04% to 48,710.97.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 28.69% short of its 52-week high of $2.44, which the company reached on January 3rd.The stock outperformed some of its competitors Friday, as AbbVie Inc.  rose 0.04% to $229.98.Trading volume  remained 253,632 below its 50-day average volume of 288,007.Data source: Dow Jones Market Data, FactSet. Data compiled December 26, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2594026114","title":"TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2594026114","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594026114?lang=en_us&edition=fundamental","pubTime":"2025-12-25 05:32","pubTimestamp":1766611920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. rose 3.7% to $1.70 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 23,613.31 and the Dow Jones Industrial Average rising 0.6% to 48,731.16.The stock's rise snapped a two-day losing streak.TherapeuticsMD Inc. closed 30.3% short of its 52-week high of $2.44, which the company reached on January 3rd.The stock outperformed some of its peers, as AbbVie Inc. rose 0.5% to $229.89.Trading volume totaled 38,137, compared to the 50-day average of 287,105.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2593455962","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455962?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:32","pubTimestamp":1766442720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 1.18% to $1.68 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.52% to 23,428.83 and the Dow Jones Industrial Average  rising 0.47% to 48,362.68.TherapeuticsMD Inc. closed 31.15% below its 52-week high of $2.44, which the company achieved on January 3rd.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 0.48% to $227.91.Trading volume  remained 198,646 below its 50-day average volume of 286,872.Data source: Dow Jones Market Data, FactSet. Data compiled December 22, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2592080946","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2592080946","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592080946?lang=en_us&edition=fundamental","pubTime":"2025-12-18 06:30","pubTimestamp":1766010600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 3.09% to $1.67 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 1.81% to 22,693.32 and Dow Jones Industrial Average  falling 0.47% to 47,885.97.The stock's rise snapped a four-day losing streak.TherapeuticsMD Inc. closed 31.56% below its 52-week high of $2.44, which the company achieved on January 3rd.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  rose 0.29% to $224.31.Trading volume  remained 234,174 below its 50-day average volume of 284,350.Data source: Dow Jones Market Data, FactSet. Data compiled December 17, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2592937658","title":"TherapeuticsMD Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937658","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592937658?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:01","pubTimestamp":1765918912,"startTime":"0","endTime":"0","summary":"TherapeuticsMD Inc. held its annual meeting of stockholders on December 15, 2025. During the meeting, stockholders elected four directors to the board, approved the ratification of the company's independent auditor for the fiscal year ending December 31, 2025, and approved an amendment to increase the number of authorized shares of common stock to 640,000,000. Stockholders also approved holding future non-binding advisory votes on executive compensation on an annual basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TherapeuticsMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on De","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDLbzZRyG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD","BK4007"],"gpt_icon":0},{"id":"2591185627","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2591185627","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591185627?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:32","pubTimestamp":1765837920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 2.86% to $1.70 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.59% to 23,057.41 and Dow Jones Industrial Average  falling 0.09% to 48,416.56.This was the stock's third consecutive day of losses.TherapeuticsMD Inc. closed 30.33% below its 52-week high of $2.44, which the company achieved on January 3rd.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 1.85% to $227.45.Trading volume  remained 239,281 below its 50-day average volume of 283,637.Data source: Dow Jones Market Data, FactSet. Data compiled December 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2590423965","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590423965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590423965?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:31","pubTimestamp":1765492260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 2.13% to $1.84 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.34% to 48,704.01 and the NASDAQ Composite Index  falling 0.25% to 23,593.86.The stock's fall snapped a two-day winning streak.TherapeuticsMD Inc. closed 24.59% below its 52-week high of $2.44, which the company reached on January 3rd.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  fell 0.53% to $223.98.Trading volume  remained 204,897 below its 50-day average volume of 282,951.Data source: Dow Jones Market Data, FactSet. Data compiled December 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2590832207","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2590832207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590832207?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:28","pubTimestamp":1765319280,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 2.41% to $1.70 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.13% to 23,576.49 and the Dow Jones Industrial Average  falling 0.38% to 47,560.29.TherapeuticsMD Inc. closed 30.33% below its 52-week high of $2.44, which the company reached on January 3rd.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  fell 0.06% to $222.99.Trading volume  remained 241,448 below its 50-day average volume of 279,136.Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2590136654","title":"TherapeuticsMD Inc. Stock Sheds 4.6%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2590136654","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590136654?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:32","pubTimestamp":1765229520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 4.6% to $1.66 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 23,545.90 and Dow Jones Industrial Average falling 0.4% to 47,739.32.The stock's fall snapped a three-day winning streak.TherapeuticsMD Inc. closed 32.0% short of its 52-week high of $2.44, which the company reached on January 3rd.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 1.3% to $223.12.Trading volume totaled 28,921, compared to the 50-day average of 278,421.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":0.1704},{"period":"1month","weight":0.5353},{"period":"3month","weight":1.0233},{"period":"6month","weight":1.1933},{"period":"1year","weight":1.4167},{"period":"ytd","weight":0.6012}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.09035},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.042264},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.005549},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.018646},{"month":5,"riseRate":0.538462,"avgChangeRate":0.005178},{"month":6,"riseRate":0.538462,"avgChangeRate":0.001172},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.043284},{"month":8,"riseRate":0.461538,"avgChangeRate":0.045617},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.025286},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.071876},{"month":11,"riseRate":0.615385,"avgChangeRate":0.054051},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.035764}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}